Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Monsanto Co. -- Ignore unavailable to you. Want to Upgrade?

To: Anthony Wong who wrote (474)	11/9/1998 3:01:00 PM
From: Anthony Wong	Read Replies (1) \| Respond to of 2539

Novartis Loses Bid for $194 Mln in Corn Patent Suit (Update1) Bloomberg News November 9, 1998, 2:13 p.m. ET Novartis Loses Bid for $194 Mln in Corn Patent Suit (Update1) (Adds comment, background in 5th through 10th paragraphs. Updates stock prices in 12th paragraph.) Wilmington, Delaware, Nov. 9 (Bloomberg) -- Novartis AG, the world's largest agricultural products company, lost a bid to collect $194 million from Monsanto Co. and DeKalb Genetics Corp. when a jury invalidated Novartis' corn seed patent. After three hours of deliberation following a two-week trial, a federal jury of five women and four men in Wilmington, Delaware today also said Basel, Switzerland-based Novartis failed to prove that Monsanto or DeKalb infringed on patent claims. The patent, filed in 1987, was awarded last year. The verdict was a significant victory for St. Louis-based Monsanto and Illinois-based DeKalb, which claimed that their scientists invented the technology for inserting a modified Bacillus thuringiensis (Bt) gene into corn plants to produce a protein that kills corn-eating insects. The market for such bioengineered crops could reach $20 billion in the next decade, analysts say. ''We're extremely pleased with the outcome. This reaffirms that we are the pioneers with DeKalb in this form of biotechnology,'' said Monsanto lawyer David Snively. Novartis said it plans to appeal. Edward Resler, a lawyer for Novartis' U.S. unit, said the company was ''disappointed,'' but added that ''the outcome will not affect Novartis' ability to supply (Bt) corn hybrids to farmers.'' It's now questionable whether either Monsanto or Novartis has an exclusive legal claim on the pest-resistant corn since juries have invalidated patents of both companies. In June, a federal jury in Delaware decided that Novartis and San Diego-based Mycogen Corp. -- a unit of Midland, Michigan- based Dow Chemical Co. -- did not infringe on a Monsanto Bt corn patent and invalidated that patent. In the latest case, Novartis claimed Monsanto and DeKalb should pay up to $194 million in lost sales and royalties because they allegedly used Novartis' patented process for making the corn seed. The suit was filed in 1997. Key Question A key question in the case was whether laboratory workers could make viable Bt corn plants using the recipe laid out in the Novartis patent. Dimitrios Drivas, a Novartis lawyer, told the jury in closing arguments that ''as long as you're following these same methods, you can do it (make Bt plants).'' Monsanto attorney John Lynch countered that Novartis' 1987 patent application was merely ''prophetic'' because the company couldn't produce Bt-filled corn seeds. ''There was not a solitary glimmer of success'' for Novartis in developing viable Bt corn seed until 1994, Lynch added. Tom Brakel, an analyst at Mehta Partners in New York who follows Monsanto, said today's decision will protect the life- sciences company's financial flanks. ''It would have been bad for Monsanto to have to spend any money at this time since their resources are strapped,'' said Brakel, who has a ''Neutral'' recommendation on the company's shares. Monsanto's coffers are depleted after the company went on a buying binge, acquiring agricultural seed businesses as part of its strategy to become the dominant player in the life-sciences industry. In May, Monsanto offered $1.82 billion for Delta & Pine Land Co., which sells cotton and soybean seeds. The next month, Monsanto agreed to buy Cargill Inc.'s international seed business for $1.4 billion to gain a worldwide distribution network for its plant genetics technology. Then in July it bought Unilever Plc's wheat-seed unit for $520 million. Shares of Novartis fell 16 francs to 2,467 today in Zurich. American depositary receipts of Novartis, with a U.S. unit in Golden Valley, Minnesota, rose 3/4 to 91 when last traded Friday. Monsanto fell 1 1/16 to 38 7/8 in afternoon trading today. DeKalb shares fell 9/16 90 5/16. --Phil Milford and Jef Feeley in Wilmington, Delaware (302) 984-